Circulating Tumor Cells and Liquid Biopsy 2017

Molecular traces of cancer can be found in circulation early in the disease. Analysis of biomarker signatures are yielding remarkable insights into early detection, disease progression, therapy monitoring and treatment selection in oncology. Liquid biopsy offers the promise to achieve greater success in our treatment of cancer, but many aspects of this field need to be improved in the isolation and characterization of circulating tumor cells, cell-free circulating DNA, exosomes and extracellular vesicles. This meeting will shed light on novel emerging technologies, analytical validation and clinical implementation. Don’t miss the industry’s leading event on liquid biopsy learn about important discoveries and network with your peers.